Entrevistas con miembros académicos


 
CARDIOVASCULAR RISKS IN DIABETES: NEW INSIGHTS FROM SIMPLE OBSERVATIONS
 
10
What are the most important messages for HCPs treating diabetes about the link between diabetes and excess weight with respect to cardiovascular risk including glycaemia levels?
122
Given the age of diabetes onset seems to matter enormously to prognosis, how do these findings translate to clinical care in the young or very old diagnosed with diabetes?
244
Do South Asians differ from other populations in terms of progression of type 2 diabetes over time?
391
How has the COVID-19 pandemic affected management of patients with diabetes? What does the future hold?

 

 
NEW LESSONS ABOUT DIABETIC COMPLICATIONS: 30 YEARS AND COUNTING IN THE DCCT/EDIC
 
10
What important lessons were learned from DCCT?
145
What is the ECID, the follow-up of DCCT, telling us about type 1 diabetes?
186
What can be expected from ECID over the next 10-20 years?

 

 
EASD/ADA SYMPOSIUM: ADA/EASD PRECISION MEDICINE IN DIABETES INITIATIVE
 
10
Does the Precision Medicine in Diabetes Initiative represent a roadmap for future management?
194
What are the key elements of precision medicine in diabetes?
557
How important is individual genetics in precision diabetes care?

 

 
EFFECT OF DULAGLUTIDE ON KIDNEY FUNCTION-RELATED OUTCOMES IN TYPE 2 DIABETES: POST HOC ANALYSIS FROM THE REWIND TRIAL
 
10
What information does the post hoc analysis on renal function with dulaglutide add to the current knowledge base?
150
How relevant are the findings to daily practice?
270
Are additional studies needed to consolidate these results and further evaluate progression of diabetic kidney disease in patients treated with dulaglutide?

 

 
NEW APPROACHES TO REDUCING HYPOGLYCAEMIA: HYPE OR HOPE - THERAPEUTIC INTERVENTIONS
 
10
Do newer treatment modalities such as insulin analogues, insulin pumps and continuous glucose monitoring systems have the potential to reduce the risk of hypoglycaemia? Is additional evidence needed?
88
How do patients view some of the new treatment approaches?

 

 

 
PHYSICAL ACTIVITY IN T1D
 
10
How to manage insulin therapy around exercise?
119
What are the benefits and limits of CGM around physical activity?
261
How can the physician/patient relation be reinforced so that physical activity is encouraged?